Imaging software company 4DMedical has secured more than $100 million in new funding to accelerate its U.S. expansion.
With the financing, 4DMedical has reported a pro forma cash position exceeding $130 million.
According to the firm, the funds will be used for commercial expansion across U.S. academic medical centers and health systems, with a focus on real-world adoption and multidisciplinary use.
Additionally, 4DMedical said that it plans to use the funds to develop training and technical support to help users integrate its CT:VQ imaging software as a service (SaaS) into existing clinical workflows, scale hospital deployments of CT:VQ, advance its R&D, support early adopters of CT:VQ, and improve operational scale and flexibility.
CT:VQ is a U.S. Food and Drug Administration-cleared SaaS technology that provides ventilation and perfusion insights from CT imaging, designed to integrate with existing infrastructure.
4DMedical added that it will emphasize strategic partnerships going forward, including with Philips, aimed at supporting broader adoption pathways.
